-
1
المؤلفون: Gaëlle Farge, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sheenu Chandwani, Caroline Dutriaux, Sophie Dalac, Laurie Levy-Bachelot, Laetitia Verdoni, Emilie Scherrer, Clara Allayous, Céleste Lebbé, Emilie Casarotto, B. Oriano
المساهمون: MSD France, Merck & Co. Inc, CHU Lille, Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Saint-André, CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
المصدر: Immunotherapy
Immunotherapy, 2021, 13 (11), pp.905-916. ⟨10.2217/imt-2021-0077⟩مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Skin Neoplasms, Databases, Factual, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Pembrolizumab, Antibodies, Monoclonal, Humanized, computer.software_genre, Tumor response, survival, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, cohort study, medicine, Overall survival, Humans, Immunology and Allergy, Stage (cooking), Immune Checkpoint Inhibitors, Melanoma, Aged, Advanced melanoma, Aged, 80 and over, Database, business.industry, Immunotherapy, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, immunotherapy, pembrolizumab, France, business, computer, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eeecf15ac2f76c4e915b9fc7920c053Test
https://doi.org/10.2217/imt-2021-0077Test -
2
المؤلفون: Cathy A Pinto, Xinyue Liu, Xiaoyun Li, Emilie Scherrer, Mizuho Kalabis
المصدر: Immunotherapy. 14(4)
مصطلحات موضوعية: Male, Databases, Factual, Immunology, Programmed Cell Death 1 Receptor, Middle Aged, Survival Analysis, Cohort Studies, Treatment Outcome, Oncology, Disease Progression, Immunology and Allergy, Humans, Female, Immunotherapy, Melanoma, Aged, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac074913462573af98a533bb5bbc2bdTest
https://pubmed.ncbi.nlm.nih.gov/34870445Test -
3
المؤلفون: Anvi Khandelwal, Baanie Sawhney, John Cook, Emilie Scherrer, Shalini Bagga, Raquel Aguiar-Ibáñez, Dmitri Grebennik, Scott Soefje
المصدر: Journal for ImmunoTherapy of Cancer. 9:A941-A941
مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, Schedule, business.industry, Melanoma, medicine.medical_treatment, Immunology, Pembrolizumab, medicine.disease, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, Dosing, business, Adjuvant
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7af1f3e3202f213bbd013952090a7809Test
https://doi.org/10.1136/jitc-2021-sitc2021.897Test -
4
المؤلفون: Emilie Scherrer, Eric Druyts, Hussein Tawbi, Irene Shui, Andrew Frederickson
المصدر: Journal for ImmunoTherapy of Cancer. 9:A339-A339
مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Immunology, Anti pd 1, Immunotherapy, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, business, Advanced melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c80f3173bbaed1027f6f5053ec9ed425Test
https://doi.org/10.1136/jitc-2021-sitc2021.315Test